A small-scale clinical trial of the combined use of the AstraZeneca and Sputnik Light vaccines against Covid-19 has shown strong antibody growth in a majority of the study’s participants, the Russian Direct Investment Fund said on Sept. 27.
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca’s shot revealed no serious side effects and no subsequent cases of coronavirus among volunteers, the Russian Direct Investment Fund (RDIF) said on July 30.
